Literature DB >> 6998384

Induction of ovulation with chronic intermittent (pulsatile) administration of LH-RH in women with hypothalamic and hyperprolactinemic amenorrhea.

G Leyendecker, T Struve, E J Plotz.   

Abstract

Five women with hypothalamic amenorrhea were treated with LH-RH (10-15 microg i.v. at 90 min intervals for 17-20 days). In all women this chronic intermittent LH-RH administration resulted in a normalization of serum gonadotropin levels. Four women exhibited preovulatory estradiol serum levels with subsequent LH peaks. In three women the LH peaks were followed by normal luteal phase serum progesterone levels. One woman with hyperprolactinemic amenorrhea was also treated with the same therapeutic regimen which induced ovulation as judged from normal luteal phase serum progesterone levels. The results indicate that normal pituitary-ovarian function can be established in hypothalamic amenorrhea by chronic intermittent administration of LH-RH. They also suggest that in the human female hypothalamic LH-RH function may be only permissive in that the cyclicity of endocrine events during the menstrual cycle is regulated on pituitary and ovarian levels. Hyperproactinemic amenorrhea appears to be associated with insufficient endogenous LH-RH secretion which can be substituted by exogenous chronic intermittent administration of LH-RH. Elevated prolactin levels per se do not interfere with the pituitary positive feedback mechanisms nor with the gonadotropin action on the ovarian level.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6998384     DOI: 10.1007/bf02108310

Source DB:  PubMed          Journal:  Arch Gynecol        ISSN: 0170-9925


  19 in total

1.  Successful induction of follicular maturation and ovulation by prolonged treatment with LH-releasing hormone in women with anorexia nervosa.

Authors:  S J Nillius; H Fries; L Wide
Journal:  Am J Obstet Gynecol       Date:  1975-08-15       Impact factor: 8.661

2.  The pathophysiology of hypothalamic ovarian failure. Diagnostic and therapeutical considerations.

Authors:  G Leyendecker
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1979       Impact factor: 2.435

3.  The functional changes of the pituitary gonadotrophs during the menstrual cycle.

Authors:  C F Wang; B L Lasley; A Lein; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1976-04       Impact factor: 5.958

4.  A possible role for prolactin in control of steroid secretion by the human Graafian follicle.

Authors:  K P McNatty; R S Sawers; A S McNeilly
Journal:  Nature       Date:  1974-08-23       Impact factor: 49.962

Review 5.  Pituitary and gonadal hormones in women during spontaneous and induced ovulatory cycles.

Authors:  G T Ross; C M Cargille; M B Lipsett; P L Rayford; J R Marshall; C A Strott; D Rodbard
Journal:  Recent Prog Horm Res       Date:  1970

6.  Pulsatile patterns of gonadotropin release in subjects with and without ovarian function.

Authors:  S S Yen; C C Tsai; F Naftolin; G Vandenberg; L Ajabor
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

7.  Further improvements in the radioimmunoassay of human pituitary follicle-stimulating hormone (FSH).

Authors:  G Leyendecker; D M Saunders; B B Saxena
Journal:  Klin Wochenschr       Date:  1971-06-01

8.  [LH, FSH and ovarian steroids in serum during normal menstrual cycles and cycles with corpus luteum insufficiency in the human female (author's transl)].

Authors:  G Leyendecker; K Hinckers; W Nocke; E J Plotz
Journal:  Arch Gynakol       Date:  1975

9.  Luteinizing hormone-releasing hormone in human pituitary blood.

Authors:  J L Antunes; P W Carmel; E M Housepian; M Ferin
Journal:  J Neurosurg       Date:  1978-09       Impact factor: 5.115

10.  The effect of D-ser (TBU)6-LH-RH-EA10 upon gonadotropin release in normally cyclic women.

Authors:  J S Dericks-Tan; E Hammer; H D Taubert
Journal:  J Clin Endocrinol Metab       Date:  1977-09       Impact factor: 5.958

View more
  12 in total

Review 1.  [Pulsatile therapy with LHRH].

Authors:  M H Birkhäuser
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

Review 2.  Pharmacologic resistance in prolactinoma patients.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

3.  Pulsatile LHRH therapy for induction of ovulation in patients with hyperprolactinaemia and bromocriptine intolerance.

Authors:  J M Wilson; A B Atkinson; B Sheridan; A I Traub; J M Harley
Journal:  Ir J Med Sci       Date:  1987-08       Impact factor: 1.568

4.  The impact of dosage on ovulation induction by pulsatile gonadotropin-releasing hormone (Gn-RH) in hypothalamic amenorrhea.

Authors:  A Caruso; A Lanzone; A M Fulghesu; S Mancuso
Journal:  J Endocrinol Invest       Date:  1987-10       Impact factor: 4.256

5.  Induction of ovulation with pulsatile luteinising hormone releasing hormone.

Authors:  P Mason; J Adams; D V Morris; M Tucker; J Price; Z Voulgaris; Z M Van der Spuy; I Sutherland; G R Chambers; S White
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-21

Review 6.  Dopamine resistance of prolactinomas.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

7.  Pulsatile luteinizing hormone releasing hormone treatment for induction of ovulation. Radioimmunoassay of plasma LHRH and comparative study of subcutaneous versus intravenous routes of administration.

Authors:  B Couzinet; N Lahlou; N Lestrat; P Bouchard; M Roger; G Schaison
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

8.  Effects of estradiol and some antiestrogens (clomiphene, tamoxifen, and hydroxytamoxifen) on luteinizing hormone secretion by rat pituitary cells in culture.

Authors:  G Emons; O Ortmann; S Thiessen; R Knuppen
Journal:  Arch Gynecol       Date:  1986

9.  Sexual maturation of the hypothalamus: pathophysiological aspects and clinical implications.

Authors:  M G Forest
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

10.  Development of a radioimmunoassay for measuring gonadotrophin releasing hormone in patients receiving treatment.

Authors:  V A Mosby; M L Knapp; R S Fink; V M Osgood; P D Mayne
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.